https://www.marketscreener.com/quote/stock/EXELIXIS-INC-9235/news/Exelixis-and-Iconic-Therapeutics-Enter-into-Exclusive-Option-and-License-Agreement-for-Novel-Antib-28608088/?utm_source=telegram&utm_medium=social&utm_campaign=share